DOES CLOZAPINE CAUSE TARDIVE-DYSKINESIA

被引:0
|
作者
KANE, JM
WOERNER, MG
POLLACK, S
SAFFERMAN, AZ
LIEBERMAN, JA
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[2] ST JOHNS UNIV,DEPT QUANTITAT ANAL,QUEENS,NY
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: The authors attempted to determine if chronic exposure to clozapine can cause tardive dyskinesia. Method: Twenty-eight schizophrenic or schizoaffective patients with no prior history of definite tardive dyskinesia were treated with clozapine for at least 1 year, and their ongoing modified Simpson Dyskinesia Scale ratings were analyzed. These data were then compared with those of another group of similarly diagnosed patients who were treated with a conventional neuroleptic for at least 1 year. Results: Two patients in the clozapine-treated group (both of whom had ratings of questionable tardive dyskinesia at baseline) were later rated by the modified Simpson Dyskinesia Scale as having mild tardive dyskinesia on at least two consecutive ratings 3 months apart. Although there was uncertainty about whether clozapine definitely caused the tardive dyskinesia in those two patients, a survival analysis comparing the clozapine-treated group with the neuroleptic-treated group showed a lower risk of tardive dyskinesia developing in the clozapine-treated group. Conclusion: This study was unable to definitively conclude whether clozapine causes tardive dyskinesia. However, if cases do develop, the risk of tardive dyskinesia is likely to be less with clozapine than with typical neuroleptics.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 50 条
  • [1] CLOZAPINE AND TARDIVE-DYSKINESIA
    SINGER, JM
    ARCHIVES OF GENERAL PSYCHIATRY, 1983, 40 (03) : 347 - 347
  • [2] CLOZAPINE IN TARDIVE-DYSKINESIA
    SIMPSON, GM
    LEE, JH
    SHRIVASTAVA, RK
    PSYCHOPHARMACOLOGY, 1978, 56 (01) : 75 - 80
  • [3] CLOZAPINE FOR TARDIVE-DYSKINESIA IN ADOLESCENTS
    LEVKOVITCH, Y
    KRONENBERG, J
    KAYSER, N
    ZVYAGELSKI, M
    GAONI, B
    GADOTH, N
    BRAIN & DEVELOPMENT, 1995, 17 (03): : 213 - 215
  • [4] CLOZAPINE EFFECTS ON TARDIVE-DYSKINESIA
    LIEBERMAN, JA
    SALTZ, BL
    JOHNS, CA
    POLLACK, S
    KANE, JM
    PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (01) : 57 - 62
  • [5] CLOZAPINE PHARMACOLOGY AND TARDIVE-DYSKINESIA
    LIEBERMAN, J
    JOHNS, C
    COOPER, T
    POLLACK, S
    KANE, J
    PSYCHOPHARMACOLOGY, 1989, 99 : S54 - S59
  • [6] THE EFFECTS OF CLOZAPINE ON TARDIVE-DYSKINESIA
    LIEBERMAN, JA
    SALTZ, BL
    JOHNS, CA
    POLLACK, S
    BORENSTEIN, M
    KANE, J
    BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 : 503 - 510
  • [7] CLOZAPINE AND TARDIVE-DYSKINESIA - PROSPECTIVE DATA
    KANE, JM
    LIEBERMAN, J
    POLLACK, S
    SAFFERMAN, A
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 364 - 365
  • [8] CLOZAPINE-RELATED TARDIVE-DYSKINESIA
    DAVE, M
    BIOLOGICAL PSYCHIATRY, 1994, 35 (11) : 886 - 887
  • [9] THE PREVALENCE OF AKATHISIA AND TARDIVE-DYSKINESIA IN PATIENTS ON CLOZAPINE
    CHENGAPPA, KNR
    SHELTON, MD
    BAKER, RW
    SCHOOLER, NR
    BAIRD, J
    DELANEY, J
    BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) : A126 - A126
  • [10] HIGH PLASMA CLOZAPINE LEVELS IN TARDIVE-DYSKINESIA
    POLLACK, S
    LIEBERMAN, J
    KLEINER, D
    SZYMANSKI, S
    KANE, J
    BORENSTEIN, M
    COOPER, T
    PSYCHOPHARMACOLOGY BULLETIN, 1993, 29 (02) : 257 - 262